ProgenaBiome Links Anxiety Disorders to Gut Dysbiosis

ProgenaBiome, a genetics research lab, is at the forefront of a groundbreaking investigation into the correlation between anxiety disorders and the microbiome. Anxiety disorders are the most common mental health issue worldwide, affecting an estimated 301 million individuals. ProgenaBiome's research has unveiled a pattern of gut dysbiosis - an imbalance in gut bacteria - linked to the development of anxiety. This study is a pioneering effort to identify specific microbes associated with anxiety, potentially laying the groundwork for new treatments involving live bacterial formulas.

Implications of ProgenaBiome's Research

The implications of this research go beyond anxiety, suggesting that gut dysbiosis may also be connected to other mental health conditions. This revelation indicates a wider field of study involving mental illness and the microbiome. The work of ProgenaBiome has earned recognition from the Anxiety and Depression Association of America (ADAA), which accepted their abstract last month.

Community Support and Expansion

To further their research, ProgenaBiome is expanding its research team and seeking support from the community and the Microbiome Research Foundation. The foundation, which assists patients with microbiome-related diseases through donations and the sale of Biomeboosters, is preparing for its 4th annual Malibu Microbiome Meeting in August 2024.

Market Collaboration and Future Plans

ProgenaBiome is also keen on forging partnerships with investors to bring verified, reproducible assays to the market. More information about their research and mission can be found on their website, progenabiome.com, with updates regularly shared by Dr. Sabine Hazan on social media.